CCM
ATHN

CrestPoint Capital Management’s Athenahealth, Inc. ATHN Stock Holding History

CrestPoint Capital Management’s Portfolio ATHN Stock Details ATHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,400
Closed -$298K – 229
2017
Q3 		$298K Hold
2,400
– – 0.13% 195
2017
Q2 		$337K Buy
+2,400
New +$300K 0.16% 179
2016
Q3 		– Sell
-7,000
Closed -$966K – 245
2016
Q2 		$966K Hold
7,000
– – 0.51% 66
2016
Q1 		$971K Buy
+7,000
New +$960K 0.53% 62

Other funds holding ATHN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

CrestPoint Capital Management's ATHN Position: Q4 2017 in Review

CrestPoint Capital Management sold out of Athenahealth, Inc. (ATHN) in Q4 2017, closing a stake of 2,400 shares — an estimated $298K sold.

CrestPoint Capital Management first reported a position in ATHN in Q1 2016 and held it in 4 quarters. The position peaked at $971K in Q1 2016. 235 funds tracked by Wall St. Rank hold ATHN as of Q4 2017.

  • CrestPoint Capital Management reported no remaining Athenahealth, Inc. position as of Q4 2017 after selling out during the quarter.
  • CrestPoint Capital Management sold 2,400 Athenahealth, Inc. shares in Q4 2017, an estimated $298K.
  • CrestPoint Capital Management first reported a position in Athenahealth, Inc. in Q1 2016 and held it in 4 quarters.
  • CrestPoint Capital Management's Athenahealth, Inc. position peaked at $971K in Q1 2016.
  • 235 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q4 2017.

Based on CrestPoint Capital Management's 13F filing for Q4 2017, filed 17 Jan 2018.